64 related articles for article (PubMed ID: 26103543)
41. TNF alpha as a therapeutic target in rheumatoid arthritis.
Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
[TBL] [Abstract][Full Text] [Related]
42. Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Burska AN; Sakthiswary R; Sattar N
PLoS One; 2015; 10(6):e0128889. PubMed ID: 26110878
[TBL] [Abstract][Full Text] [Related]
43. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
Segal B; Rhodus NL; Patel K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
[TBL] [Abstract][Full Text] [Related]
44. TNF inhibitors - new and old agents for rheumatoid arthritis.
Simsek I
Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
[TBL] [Abstract][Full Text] [Related]
45. [Insulin resistance and rheumatoid arthritis].
Ferraz Amaro I; Díaz González F; González Juanatey C; González Gay MA
Reumatol Clin; 2011; 7(2):124-9. PubMed ID: 21794795
[TBL] [Abstract][Full Text] [Related]
46. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
Choy E
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
[TBL] [Abstract][Full Text] [Related]
47. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
Meroni PL; Valesini G
BioDrugs; 2014 Apr; 28 Suppl 1():S5-13. PubMed ID: 24687234
[TBL] [Abstract][Full Text] [Related]
48. Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.
Toussirot É
Expert Opin Drug Saf; 2015 Apr; 14(4):525-32. PubMed ID: 25599626
[TBL] [Abstract][Full Text] [Related]
49. [TNF inhibitors].
Kameda H
Nihon Rinsho; 2016 Jun; 74(6):957-62. PubMed ID: 27311185
[TBL] [Abstract][Full Text] [Related]
50. The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis.
Peters MJ; van Sijl AM; Voskuyl AE; Sattar N; Smulders YM; Nurmohamed MT
Curr Pharm Des; 2012; 18(11):1502-11. PubMed ID: 22364134
[TBL] [Abstract][Full Text] [Related]
51. Metabolic syndrome in rheumatoid arthritis.
Ferraz-Amaro I; González-Juanatey C; López-Mejias R; Riancho-Zarrabeitia L; González-Gay MA
Mediators Inflamm; 2013; 2013():710928. PubMed ID: 23431244
[TBL] [Abstract][Full Text] [Related]
52. Association of Rheumatoid Arthritis with Diabetic Comorbidity: Correlating Accelerated Insulin Resistance to Inflammatory Responses in Patients.
Verma AK; Bhatt D; Goyal Y; Dev K; Beg MMA; Alsahli MA; Rahmani AH
J Multidiscip Healthc; 2021; 14():809-820. PubMed ID: 33880030
[TBL] [Abstract][Full Text] [Related]
53. [TNF-alpha and insulin-resistance: metabolic effects of in vivo therapeutic blockade].
Ursini F
Reumatismo; 2009; 61(4):254-9. PubMed ID: 20143002
[TBL] [Abstract][Full Text] [Related]
54. Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Wang CR; Tsai HW
World J Diabetes; 2021 Mar; 12(3):238-260. PubMed ID: 33758645
[TBL] [Abstract][Full Text] [Related]
55. Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.
Pilla SJ; Quan AQ; Germain-Lee EL; Hellmann DB; Mathioudakis NN
Curr Diab Rep; 2016 Oct; 16(10):91. PubMed ID: 27525682
[TBL] [Abstract][Full Text] [Related]
56. Role for TNF in atherosclerosis? Lessons from autoimmune disease.
McKellar GE; McCarey DW; Sattar N; McInnes IB
Nat Rev Cardiol; 2009 Jun; 6(6):410-7. PubMed ID: 19421244
[TBL] [Abstract][Full Text] [Related]
57. Pain in systemic inflammatory rheumatic diseases.
Atzeni F; Masala IF; Salaffi F; Di Franco M; Casale R; Sarzi-Puttini P
Best Pract Res Clin Rheumatol; 2015 Feb; 29(1):42-52. PubMed ID: 26266998
[TBL] [Abstract][Full Text] [Related]
58. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.
Popa C; Netea MG; van Riel PL; van der Meer JW; Stalenhoef AF
J Lipid Res; 2007 Apr; 48(4):751-62. PubMed ID: 17202130
[TBL] [Abstract][Full Text] [Related]
59. The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis.
Ursini F; Russo E; Ruscitti P; Giacomelli R; De Sarro G
Autoimmun Rev; 2018 Apr; 17(4):399-404. PubMed ID: 29452240
[TBL] [Abstract][Full Text] [Related]
60. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
Danve AS; Kulkarni S
Am J Ther; 2017 May; 24(3):e347-e350. PubMed ID: 26103543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
